Lauren T. Roland

Lauren T. Roland

Auto-generated profile, based on publicly available information

Lauren T. Roland

Department of Otolaryngology–Head and Neck Surgery Washington University in St. Louis School of Medicine St. Louis Missouri USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2023 in International Forum of Allergy & Rhinology
Verified
Journal Article
Open access
SWSarah K. Wise
Sarah K. Wise
CDCecelia Damask
Cecelia Damask
LRLauren T. Roland
Lauren T. Roland
CECharles Ebert
Charles Ebert
JLJoshua Levy
Joshua Levy
LZLuo Zhang
Luo Zhang
Background: In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR‐Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence‐based findings and recommendation from the full document.Methods: ICAR‐Allergic Rhinitis 2023 employed established evidence‐based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work.Results: ICAR‐Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost.Conclusion: The ICAR‐Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. It is this evidence that contributes to our current knowledge base and recommendations for patient evaluation and treatment.

7 June 2020 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
PDF file
LRLauren T. Roland
Lauren T. Roland
JGJose G. Gurrola
Jose G. Gurrola
PLPatricia A. Loftus
Patricia A. Loftus
SCSteven W. Cheung
Steven W. Cheung
JCJolie L. Chang
Jolie L. Chang

10 October 2019 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
PDF file
SMSonya Marcus
Sonya Marcus
JSJoseph Schertzer
Joseph Schertzer
LRLauren T. Roland
Lauren T. Roland
SWSarah K. Wise
Sarah K. Wise
JLJoshua Levy
Joshua Levy
JDJohn M. DelGaudio
John M. DelGaudio

19 February 2023 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
LRLauren T. Roland
Lauren T. Roland
IHIan M. Humphreys
Ian M. Humphreys
CLChristopher H. Le
Christopher H. Le
JBJennifer M. Babik
Jennifer M. Babik
CBChristopher E. Bailey
Christopher E. Bailey
Edward C KuanEdward C Kuan
Edward C Kuan

2 June 2020 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
PDF file
LRLauren T. Roland
Lauren T. Roland
TSTimothy L. Smith
Timothy L. Smith
RSRodney J. Schlosser
Rodney J. Schlosser
ZSZachary M. Soler
Zachary M. Soler
APAnju T. Peters
Anju T. Peters
ALAmber U. Luong
Amber U. Luong

12 May 2020 in The Laryngoscope
Verified
Journal Article
Open access
PDF file
YCYi Cai
Yi Cai
NJNicole T. Jiam
Nicole T. Jiam
KWKatherine C. Wai
Katherine C. Wai
ESElizabeth A. Shuman
Elizabeth A. Shuman
LRLauren T. Roland
Lauren T. Roland
JCJolie L. Chang
Jolie L. Chang
Objective: The coronavirus 2019 (COVID‐19) pandemic has had widespread implications on clinical practice at U.S. hospitals. These changes are particularly relevant to otolaryngology–head and neck surgery (OHNS) residents because reports suggest an increased risk of contracting COVID‐19 for otolaryngologists. The objectives of this study were to evaluate OHNS residency program practice changes and characterize resident perceptions during the initial phase of the pandemic.Study Design: A cross‐sectional survey of U.S. OHNS residents at 81 programs was conducted between March 23, 2020, and March 29, 2020.Results: Eighty‐two residents from 51 institutions (63% of invited programs) responded. At the time of survey, 98% of programs had enacted policy changes to minimize COVID‐19 spread. These included filtered respirator use for aerosol‐generating procedures even in COVID‐19‐negative patients (85%), decreased resident staffing of surgeries (70%), and reduced frequency of tracheotomy care (61%). The majority of residents (66%) perceived that residents were at higher risk of contracting COVID‐19 compared to attendings. Residents were most concerned about protective equipment shortage (93%) and transmitting COVID‐19 to patients (90%). The majority of residents (73%) were satisfied with their department's COVID‐19 response. Resident satisfaction correlated with comfort level in discussing concerns with attendings (r = 0.72, P < .00001) and inversely correlated with perceptions of increased risk compared to attendings (r = −0.52, P < .00001).Conclusion: U.S. OHNS residency programs implemented policy changes quickly in response to the COVID‐19 pandemic. Sources of resident anxieties demonstrate the importance of open communication and an integrated team approach to facilitate optimal patient and provider care during this unprecedented crisis.Level of Evidence: 4. Laryngoscope, 130:2550–2557, 2020